115 related articles for article (PubMed ID: 15454812)
21. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
Hustinx W; Benaissa-Trouw B; Van Kessel K; Kuenen J; Tavares L; Kraaijeveld K; Verhoef J; Hoepelman A
Eur J Clin Invest; 1997 Dec; 27(12):1044-8. PubMed ID: 9466134
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model.
Haley M; Parent C; Cui X; Kalil A; Fitz Y; Correa-Araujo R; Natanson C; Danner RL; Banks SM; Eichacker PQ
J Appl Physiol (1985); 2005 Jun; 98(6):2155-62. PubMed ID: 15677732
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats.
Lundblad R; Wang MY; Kvalheim G; Lingaas E; Giercksky KE
Shock; 1995 Jul; 4(1):68-73. PubMed ID: 7552781
[TBL] [Abstract][Full Text] [Related]
24. Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection.
Solomon SB; Cui X; Gerstenberger E; Danner RL; Fitz Y; Banks SM; Natanson C; Eichacker PQ
J Infect Dis; 2006 Mar; 193(5):634-44. PubMed ID: 16453258
[TBL] [Abstract][Full Text] [Related]
25. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
26. Effects of granulocyte-colony stimulating factor on the polymorphonuclear leukocyte activity and the course of sepsis in rats with experimental peritonitis.
Gurleyik G; Yanikkaya G; Gurleyik E; Ozturk E; Dulundu E; Saglam A
Surg Today; 2007; 37(5):401-5. PubMed ID: 17468822
[TBL] [Abstract][Full Text] [Related]
27. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats.
Attalah HL; Azoulay E; Yang K; Lasclos C; Jouault H; Soussy CJ; Guillot T; Brochard L; Brun-Buisson C; Harf A; Delclaux C
Crit Care Med; 2002 Sep; 30(9):2107-14. PubMed ID: 12352049
[TBL] [Abstract][Full Text] [Related]
29. Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats.
Cantürk Z; Cantürk NZ; Onen F
Endocr Res; 1998 May; 24(2):141-57. PubMed ID: 9738693
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
[TBL] [Abstract][Full Text] [Related]
31. The effect of granulocyte colony-stimulating factor in the treatment of Escherichia coli peritonitis with or without ceftriaxone in a nonneutropenic rat model.
Saba R; Güler M; Inan D; Oğünç D; Atalay S; Mamikoğlu L; Günseren F
Surg Today; 2003; 33(7):504-8. PubMed ID: 14506994
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
34. Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor.
Torossian A; Ruehlmann S; Middeke M; Sessler DI; Lorenz W; Wulf HF; Bauhofer A
Anesthesiology; 2003 Nov; 99(5):1087-92. PubMed ID: 14576544
[TBL] [Abstract][Full Text] [Related]
35. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.
Gough A; Clapperton M; Rolando N; Foster AV; Philpott-Howard J; Edmonds ME
Lancet; 1997 Sep; 350(9081):855-9. PubMed ID: 9310604
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production.
Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S
Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide-binding protein (LBP) blockade augments the protective effect of granulocyte colony-stimulating factor (G-CSF) in a rat sepsis model.
Liu A; Weiss S; Fang H; Claus RA; Rödel J; Dirsch O; Dahmen U
Shock; 2015 May; 43(5):497-503. PubMed ID: 25874537
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis.
Bauhofer A; Lorenz W; Kohlert F; Torossian A
Crit Care Med; 2006 Mar; 34(3):778-84. PubMed ID: 16521271
[TBL] [Abstract][Full Text] [Related]
39. Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils.
Azoulay E; Attalah H; Yang K; Jouault H; Schlemmer B; Brun-Buisson C; Brochard L; Harf A; Delclaux C
Crit Care Med; 2002 Sep; 30(9):2115-22. PubMed ID: 12352050
[TBL] [Abstract][Full Text] [Related]
40. The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.
Aydin S; Caylan R; Aydin K; Yulug E; Yenilmez E; Koksal I
J Natl Med Assoc; 2005 Nov; 97(11):1489-95. PubMed ID: 16334496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
